![Crystal and molecular structure of (9aS,10S)-6-Oxo-6,7,8,9,9a,10-hexahydro-4H-thieno-[2,3-b]quinolizin-10-yl acetate Cover](https://sciendo-parsed.s3.eu-central-1.amazonaws.com/647079ea71e4585e08a9e0b2/cover-image.jpg)
References
- Allen FH, Johnson O, Shields GP, Smith BR, Towler M (2004) J. Appl. Cryst. 37: 335—338.
- Antonov KL, Hohla KL (1983) Appl. Phys. B 32: 9—14.
- Bernstein J, Davis RE, Shimoni L, Chang NL (1995) Angew. Chem. Int. Ed. Engl. 34: 1555—1573.
- Brandenburg K (2001) DIAMOND. Crystal Impact GbR, Bonn, Germany.
- Cremer D, Pople JA (1975) J. Am. Chem. Soc. 97: 1354—1362.
- Farrugia LJ (2012) J. Appl. Cryst. 45: 849—854.
- Guarna A, Occhiato EG, Machetti F, Trabocchi A, Scarpi D, Danza G, Mancina R, Comerci A, Serio M (2001) Bioorg. Med. Chem. 9: 1385—1393.
- Harris GS, Kozarich JW (1997) Curr. Opin. Chem. Biol. 1: 254—259.
- Kubo H, Kobayashi J, Higashiyama K, Kamel J, Fujii Y, Ohmiya S (2000) Biol. Pharm. Bull. 23: 1114—1117.
- Oxford Diffraction (2009) CrysAlisPro. Oxford Diffraction Ltd, Abingdon, Oxfordshire, England.
- Sheldrick GM (2008) Acta Cryst. A64: 112—122.
- Spek AL (2009) Acta Cryst. D65: 148—155.
- Šafář P, Marchalín Š, Prónayová N, Vrábel V, Lawson AM, Othman M, Daich A (2016) Tetrahedron 72: 3221—3231.